£1.4M
The pre-seed round was co-led by Laidlaw Scholars Ventures and APEX Ventures.
CB
CardiaTec Biosciences
CardiaTec Biosciences applies artificial intelligence to multiomic data for cardiovascular drug discovery.
Cambridge, UK
£1.4MTotal raised
CardiaTec Biosciences develops artificial intelligence platforms to analyse large-scale multiomic data for cardiovascular disease target discovery. The company operates from Cambridge.
Categories
Founders
RP
Raphael Peralta
CEO
TZ
Thelma Zablocki
COO
NH
Namshik Han
CTO